Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above

Clinical trial NCT04100772 · COMPLETED

Trial details

NCT number: NCT04100772
Sponsor: CanSino Biologics Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pneumococcal Infections Streptococcal Infections Bacterial Infections

Start date: 2020-05-18
Primary completion: 2021-06-23
Enrollment: 237

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.